{{Rsnum
|rsid=2608555
|Gene=GAN
|Chromosome=16
|position=81365030
|Orientation=plus
|GMAF=0.157
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GAN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.8 | 44.2 | 8.0
| HCB | 94.9 | 5.1 | 0.0
| JPT | 92.9 | 7.1 | 0.0
| YRI | 65.3 | 34.0 | 0.7
| ASW | 63.2 | 33.3 | 3.5
| CHB | 94.9 | 5.1 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 75.2 | 21.8 | 3.0
| LWK | 72.7 | 25.5 | 1.8
| MEX | 81.0 | 19.0 | 0.0
| MKK | 81.4 | 17.9 | 0.6
| TSI | 51.0 | 43.1 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21859556
|Title=Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide
}}

{{PMID Auto
|PMID=21671989
|Title=Dosing equation for tacrolimus using genetic variants and clinical factors.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}